Allogeneic CAR T cells show promise

被引：0

|

作者：

Peter Sidaway

机构：

[1] Nature Reviews Clinical Oncology,

来源：

Nature Reviews Clinical Oncology | 2022年 / 19卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：748 / 748

相关论文

共 50 条

[21] Allogeneic CAR T Cells: An Alternative to Overcome Challenges of CAR T Cell Therapy in Glioblastoma
Martinez Bedoya, Darel
Dutoit, Valerie
Migliorini, Denis
FRONTIERS IN IMMUNOLOGY, 2021, 12
[22] Will allogeneic CAR T cells for CD19+ malignancies take autologous CAR T cells 'off the shelf'?
DiNofia, Amanda M.
Grupp, Stephan A.
NATURE REVIEWS CLINICAL ONCOLOGY, 2021, 18 (04) : 195 - 196
[23] Will allogeneic CAR T cells for CD19+ malignancies take autologous CAR T cells ‘off the shelf’?
Amanda M. DiNofia
Stephan A. Grupp
Nature Reviews Clinical Oncology, 2021, 18 : 195 - 196
[24] "Off-the-Shelf" Allogeneic CAR T-Cells
Landgren, C. Ola
ONCOLOGY-NEW YORK, 2021, 35 (10): : 687 - 691
[25] Early data indicate safety of allogeneic CAR T cells
Sidaway, Peter
NATURE REVIEWS CLINICAL ONCOLOGY, 2023, 20 (04) : 209 - 209
[26] Early data indicate safety of allogeneic CAR T cells
Peter Sidaway
Nature Reviews Clinical Oncology, 2023, 20 : 209 - 209
[27] Allogeneic CAR T cells for autoimmune diseases: a glimpse into the future
Mougiakakos, Dimitrios
SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2024, 9 (01)
[28] GD2-TARGETING CAR T CELLS SHOW PROMISE IN H3K27M-MUTATED GLIOMAS
不详
CANCER DISCOVERY, 2022, 12 (04) : 882 - 882
[29] CAR T cells show superiority over standard therapies for RRMM
David Killock
Nature Reviews Clinical Oncology, 2023, 20 : 210 - 210
[30] CAR T cells show superiority over standard therapies for RRMM
Killock, David
NATURE REVIEWS CLINICAL ONCOLOGY, 2023, 20 (04) : 210 - 210

← 1 2 3 4 5 →